TIJUANA, Mexico, June 18, 2025 /CNW/ — When Michelin Tunor from Nova Scotia was diagnosed with…
Continue ReadingTag: Immunotherapy
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma
NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…
Continue Reading